Seres Therapeutics Ownership | Who Owns Seres Therapeutics?


OverviewForecastFinancialsChartTranscripts

Seres Therapeutics Ownership Summary


Seres Therapeutics is owned by 40.93% institutional investors, 13.19% insiders, and 45.87% retail investors. Flagship pioneering is the largest institutional shareholder, holding 15.14% of MCRB shares. Fidelity Growth Compy Commingled Pl S is the top mutual fund, with 5.57% of its assets in Seres Therapeutics shares.

MCRB Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockSeres Therapeutics40.93%13.19%45.87%
SectorHealthcare Stocks 57.39%9.93%32.68%
IndustryBiotech Stocks 68.48%9.65%21.87%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Flagship pioneering23.12M15.14%$19.25M
Fmr21.81M14.29%$18.13M
Vanguard group5.87M3.85%$4.88M
Blackrock1.76M1.21%$1.28M
Millennium management1.81M1.19%$1.50M
Blackrock funding, inc. /de1.76M1.15%$1.46M
Geode capital management1.51M0.99%$1.26M
Vontobel938.29K0.61%$779.72K
Charles schwab investment management865.83K0.57%$719.50K
Northern trust721.76K0.49%$522.41K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Flagship pioneering23.12M5.76%$19.25M
Lion point capital, lp340.76K1.48%$283.17K
Providence wealth advisors105.00K0.07%$94.01K
Ironwood investment management39.59K0.02%$32.90K
Bridgeway capital management250.00K0.00%$207.75K
Aries wealth management15.00K0.00%$12.46K
Vontobel938.29K0.00%$779.72K
Cantor fitzgerald, l. p.95.74K0.00%$79.56K
Arete wealth advisors20.90K0.00%$17.00K
Clear creek financial management12.95K0.00%$10.76K

Top Buyers

HolderShares% AssetsChange
Millennium management1.81M0.00%788.76K
Vontobel938.29K0.00%543.47K
Ubs group342.32K0.00%307.92K
Geode capital management1.51M0.00%121.79K
Charles schwab investment management865.83K0.00%117.11K

Top Sellers

HolderShares% AssetsChange
Blackrock1.76M--5.06M
Woodline partners lp---2.05M
State street339.55K--1.61M
Bank of america corp /de/105.04K--1.55M
Handelsbanken fonder ab---1.10M

New Positions

HolderShares% AssetsChangeValue
Two sigma investments, lp24.41K-24.41K$20.29K
Integrated wealth concepts10.00K0.00%10.00K$8.31K
Macquarie group4.95K-4.95K$3.58K
Bell investment advisors611.000.00%611.00$508.00

Sold Out

HolderChange
Headlands-10.00
Point72 (difc)-17.00
Nelson, van denburg & campbell wealth management group-20.00
Newedge advisors-200.00
Huntington national bank-230.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 202470-13.58%62,481,139-1.44%402.37%25-3.85%17-34.62%
Sep 30, 202481-14.74%63,396,268-8.26%411.86%27-41.30%26-3.70%
Jun 30, 202495-5.94%69,106,531-19.34%471.06%46-2.13%27-3.57%
Mar 31, 2024101-9.82%85,680,215-4.29%661.37%476.82%28-33.33%
Dec 31, 2023112-23.81%89,517,414-16.63%690.99%44-40.54%4231.25%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Fidelity Growth Compy Commingled Pl S9.72M5.57%17.04K
Fidelity Growth Compy Commingled Pl O9.44M5.55%92.60K
Fidelity Growth Company Fund6.79M3.90%-
Vanguard US Total Market Shares ETF4.04M2.32%-
Vanguard Total Stock Mkt Idx Inv3.86M2.21%-
Fidelity Growth Company K62.37M1.36%-60.44K
Fidelity Series Growth Company1.64M0.94%-
Vanguard Institutional Extnd Mkt Idx Tr1.45M0.83%-
Vanguard Explorer Inv1.22M0.72%-
Fidelity Select Biotechnology854.35K0.50%-

Recent Insider Transactions


DateNameRoleActivityValue
Feb 18, 2025Young Teresa L. See RemarksSell$2.70K
Feb 18, 2025Henn Matthew R. See RemarksSell$3.20K
Feb 18, 2025Shaff Eric D. CEO and PresidentSell$10.31K
Feb 18, 2025DesRosier Thomas Chief Legal Officer and EVPSell$3.49K
Feb 18, 2025von Moltke Lisa See RemarksSell$3.58K

Insider Transactions Trends


DateBuySell
2025 Q2--
2025 Q1-5
2024 Q4-10
2024 Q3-7
2024 Q2-6

MCRB Ownership FAQ


Who Owns Seres Therapeutics?

Seres Therapeutics shareholders are primarily institutional investors at 40.93%, followed by 13.19% insiders and 45.88% retail investors. The average institutional ownership in Seres Therapeutics's industry, Biotech Stocks , is 68.48%, which Seres Therapeutics falls below.

Who owns the most shares of Seres Therapeutics?

Seres Therapeutics’s largest shareholders are Flagship pioneering (23.12M shares, 15.14%), Fmr (21.81M shares, 14.29%), and Vanguard group (5.87M shares, 3.85%). Together, they hold 33.28% of Seres Therapeutics’s total shares outstanding.

Does Blackrock own Seres Therapeutics?

Yes, BlackRock owns 1.21% of Seres Therapeutics, totaling 1.76M shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 1.28M$. In the last quarter, BlackRock decreased its holdings by -5.063M shares, a -74.18% change.

Who is Seres Therapeutics’s biggest shareholder by percentage of total assets invested?

Flagship pioneering is Seres Therapeutics’s biggest shareholder by percentage of total assets invested, with 5.76% of its assets in 23.12M Seres Therapeutics shares, valued at 19.25M$.

Who is the top mutual fund holder of Seres Therapeutics shares?

Fidelity Growth Compy Commingled Pl S is the top mutual fund holder of Seres Therapeutics shares, with 5.57% of its total shares outstanding invested in 9.72M Seres Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools